Ridgetech, Inc. (RDGT)
NASDAQ: RDGT · Real-Time Price · USD
1.580
+0.040 (2.60%)
Feb 27, 2026, 11:50 AM EST - Market open
Ridgetech Market Cap
Ridgetech has a market cap or net worth of $28.89 million as of February 27, 2026. Its market cap has increased by 236.42% in one year.
Market Cap
28.89M
Enterprise Value
25.77M
1-Year Change
236.42%
Ranking
Category
Stock Price
$1.58
Market Cap Chart
Since September 29, 2009, Ridgetech's market cap has decreased from $35.40M to $28.89M, a decrease of -18.38%. That is a compound annual growth rate of -1.23%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 26, 2026 | 28.16M | -45.96% |
| Dec 31, 2025 | 52.11M | 376.55% |
| Dec 31, 2024 | 10.94M | 46.36% |
| Dec 29, 2023 | 7.47M | -75.52% |
| Dec 30, 2022 | 30.52M | 94.73% |
| Dec 31, 2021 | 15.67M | -59.12% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 913.03B |
| Johnson & Johnson | 586.74B |
| AbbVie | 397.29B |
| AstraZeneca | 316.63B |
| BriaCell Therapeutics | 28.83M |
| Dyadic International | 28.59M |
| Kyntra Bio | 28.20M |
| Pomdoctor | 27.83M |